Newronika Gets FDA IDE for U.S. Trial of Adaptive DBS System
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) from the U.S....
Category : Healthcare and Pharmaceutical
NABR Applauds CITES Decision on Cambodia’s Long-Tailed Macaques
The National Association for Biomedical Research (NABR) commends the CITES Standing Committee’s decision not to enact a trade suspension on long-tailed macaques (Macaca fascicularis) from Cambodia....
Nexalin DIFS™ Device Reduces Blood Pressure, Boosts Mental Health
Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, announces the publication of a...
Zentalis Pharmaceuticals Announces Inducement Grant under Nasdaq
Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced...
BioAro Launches AI-Powered PanOmiQ with Ultrafast Genome Tech
Transforming Genomic Medicine with Unprecedented Speed, Accuracy, and Accessibility – PanOmiQ Sets a New Standard with Analysis Time from VCF Files Under 5 Minutes, and...
Viventium Enhances Scheduling with Open Shift Management
Viventium, the leading SaaS-based human capital management platform serving the healthcare industry, announces the addition of Open Shift Management to Viventium Scheduling, Viventium’s proprietary and innovative...
Athens Orthopedic Clinic Welcomes Mike Boblitz as New CEO
New AOC CEO focused on strategy, specialization and serving the broader Athens community with accessible, world-class care Athens Orthopedic Clinic (AOC), a cornerstone of specialized...
Bristol Myers Squibb Gets CHMP Opinion for Breyanzi in Lymphoma
Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response Across clinical...
Solara Mental Health Supports HRV Biofeedback Research for Vets
Solara Mental Health proudly recognizes the doctoral research of Moe Fathi, Ph.D., from the California School of Professional Psychology, Alliant International University. His study, “The Use of...
Immunome Closes Upsized Offering, Underwriters Exercise Option
Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the closing of its underwritten public...
Inhalon Biopharma’s Inhaled RSV Antibody to Enter Trials
New at-home RSV treatment represents a potential breakthrough in addressing the burden of respiratory diseases, especially in vulnerable pediatric and elderly populations nhalon Biopharma, Inc. (Inhalon),...
Avanzanite Bioscience Appoints Chief Financial Officer
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines for rare disease patients across Europe, announces today the appointment of Abdelghani (Abdel)...
KORU Medical Announces Phase III Trial for New Nephrology Drug
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and...
Daiichi Sankyo Appoints Hiroyuki Okuzawa as Chief Executive Officer
Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive Officer (CEO), effective April 1,...
Vertex Announces CASGEVY® Reimbursement for SCD in England
– Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY – – Agreement for CASGEVY in transfusion-dependent beta thalassemia...